These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

796 related items for PubMed ID: 15538047

  • 21. Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix.
    Wu X, Tortolero-Luna G, Zhao H, Phatak D, Spitz MR, Follen M.
    Clin Cancer Res; 2003 Aug 15; 9(9):3356-61. PubMed ID: 12960122
    [Abstract] [Full Text] [Related]

  • 22. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast.
    Bohlke K, Cramer DW, Trichopoulos D, Mantzoros CS.
    Epidemiology; 1998 Sep 15; 9(5):570-3. PubMed ID: 9730040
    [Abstract] [Full Text] [Related]

  • 23. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR.
    Cancer Epidemiol Biomarkers Prev; 2003 Aug 15; 12(8):721-7. PubMed ID: 12917202
    [Abstract] [Full Text] [Related]

  • 24. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.
    Grønbaek H, Flyvbjerg A, Mellemkjaer L, Tjønneland A, Christensen J, Sørensen HT, Overvad K.
    Cancer Epidemiol Biomarkers Prev; 2004 Nov 15; 13(11 Pt 1):1759-64. PubMed ID: 15533904
    [Abstract] [Full Text] [Related]

  • 25. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women.
    Jernström H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N, Hudson T, Narod SA, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2001 Apr 15; 10(4):377-84. PubMed ID: 11319179
    [Abstract] [Full Text] [Related]

  • 26. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF, Hsing AW.
    Cancer Epidemiol Biomarkers Prev; 2001 May 15; 10(5):421-7. PubMed ID: 11352850
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES, Holly JM, Pollak MN, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar 15; 14(3):699-704. PubMed ID: 15767352
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C, Lewis SK, Voigt L, Fitzpatrick A, Plymate SR, Weiss NS.
    Cancer; 2005 Jan 01; 103(1):76-84. PubMed ID: 15540247
    [Abstract] [Full Text] [Related]

  • 31. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
    Diorio C, Brisson J, Bérubé S, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2008 Apr 01; 17(4):880-8. PubMed ID: 18398029
    [Abstract] [Full Text] [Related]

  • 32. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
    Vatten LJ, Holly JM, Gunnell D, Tretli S.
    Cancer Epidemiol Biomarkers Prev; 2008 Aug 01; 17(8):2097-100. PubMed ID: 18708402
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Body shape throughout life and correlations with IGFs and GH.
    Schernhammer ES, Tworoger SS, Eliassen AH, Missmer SA, Holly JM, Pollak MN, Hankinson SE.
    Endocr Relat Cancer; 2007 Sep 01; 14(3):721-32. PubMed ID: 17914102
    [Abstract] [Full Text] [Related]

  • 35. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
    Lacey JV, Potischman N, Madigan MP, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR, Fillmore CM, Sherman ME, Brinton LA.
    Cancer Epidemiol Biomarkers Prev; 2004 Apr 01; 13(4):607-12. PubMed ID: 15066926
    [Abstract] [Full Text] [Related]

  • 36. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ.
    Gynecol Endocrinol; 2005 Mar 01; 20(3):176-82. PubMed ID: 16019358
    [Abstract] [Full Text] [Related]

  • 37. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk.
    Zhao H, Grossman HB, Spitz MR, Lerner SP, Zhang K, Wu X.
    J Urol; 2003 Feb 01; 169(2):714-7. PubMed ID: 12544349
    [Abstract] [Full Text] [Related]

  • 38. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
    Tworoger SS, Lee IM, Buring JE, Pollak MN, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2007 Aug 01; 16(8):1691-5. PubMed ID: 17684148
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.